info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Metagenomic Sequencing Market Research Report Information By Product & Service (Reagents and Consumables, Instruments, and Services) By Technology (Shotgun Metagenomic Sequencing, 16s rRNA Sequencing, Whole Genome Sequencing and De Novo Assembly and Metatranscriptomic) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till the year 2032


ID: MRFR/LS/4149-HCR | 90 Pages | Author: Kinjoll Dey| November 2024

Metagenomic Sequencing Market Segmentation


Metagenomic Sequencing Product & Service Outlook (USD Billion, 2018-2032)




  • Reagents and Consumables




  • Instruments




  • Services




Metagenomic Sequencing Technology Outlook (USD Billion, 2018-2032)




  • Shotgun Metagenomic Sequencing




  • 16s rRNA Sequencing




  • Whole Genome Sequencing and De Novo Assembly




  • Metatranscriptomic




Metagenomic Sequencing Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • North America Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • North America Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic






    • US Outlook (USD Billion, 2018-2032)




    • US Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • US Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic






    • CANADA Outlook (USD Billion, 2018-2032)




    • CANADA Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • CANADA Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic








  • Europe Outlook (USD Billion, 2018-2032)




    • Europe Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • Europe Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic






    • Germany Outlook (USD Billion, 2018-2032)




    • Germany Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • Germany Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic






    • France Outlook (USD Billion, 2018-2032)




    • France Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • France Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic






    • UK Outlook (USD Billion, 2018-2032)




    • UK Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • UK Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic






    • ITALY Outlook (USD Billion, 2018-2032)




    • ITALY Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • ITALY Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic






    • SPAIN Outlook (USD Billion, 2018-2032)




    • Spain Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • Spain Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Rest Of Europe Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • REST OF EUROPE Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • Asia-Pacific Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic






    • China Outlook (USD Billion, 2018-2032)




    • China Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • China Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic






    • Japan Outlook (USD Billion, 2018-2032)




    • Japan Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • Japan Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic






    • India Outlook (USD Billion, 2018-2032)




    • India Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • India Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic






    • Australia Outlook (USD Billion, 2018-2032)




    • Australia Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • Australia Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Rest of Asia-Pacific Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • Rest of Asia-Pacific Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • Rest of the World Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic






    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • Middle East Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic






    • Africa Outlook (USD Billion, 2018-2032)




    • Africa Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • Africa Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic






    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America Metagenomic Sequencing by Product & Service




      • Reagents and Consumables




      • Instruments




      • Services






    • Latin America Metagenomic Sequencing by Technology




      • Shotgun Metagenomic Sequencing




      • 16s rRNA Sequencing




      • Whole Genome Sequencing and De Novo Assembly




      • Metatranscriptomic







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Metagenomic sequencing Market, by Technology

6.1 Introduction

6.2 Sequencing

6.2.1 Market Estimates & Forecast, 2020 – 2023

6.3 Bioinformatics

6.3.1 Market Estimates & Forecast, 2020 – 2023

6.4 Others

Chapter 7. Global Metagenomic sequencing Market, by Application

7.1 Introduction

7.2 Infectious disease diagnosis

7.2.1 Market Estimates & Forecast, 2023-2032

7.3 Environmental remediation

7.3.1 Market Estimates & Forecast, 2023-2032

7.4 Gut microbe characterization

7.4.1 Market Estimates & Forecast, 2023-2032

7.5 Biotechnology

7.5.1 Market Estimates & Forecast, 2023-2032

7.6 Biofuel

7.6.1 Market Estimates & Forecast, 2023-2032

7.7 Ecology

7.7.1 Market Estimates & Forecast, 2023-2032

7.8 Agriculture

7.8.1 Market Estimates & Forecast, 2023-2032

7.9 Others

Chapter 8. Global Metagenomic sequencing Market, by End User

8.1 Introduction

8.2 Hospitals

8.2.1 Market Estimates & Forecast, 2023-2032

8.3 Ambulatory Surgical Centers

8.3.1 Market Estimates & Forecast, 2023-2032

8.4 Specialized Clinics

8.4.1 Market Estimates & Forecast, 2023-2032

8.5 Others

Chapter. 9 Global Metagenomic sequencing Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 U.K

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Rest of the Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 GATC Biotech AG

11.1.1 Company Overview

11.1.2 Application Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Enterome Bioscience

11.2.1 Company Overview

11.2.2 Application Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Illumina Inc.

11.3.1 Company Overview

11.3.2 Application Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Quest Diagnostics

11.4.1 Company Overview

11.4.2 Applications/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 F Hoffman-La Roche Ltd.

11.5.1 Company Overview

11.5.2 Application Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Thermo Fisher Scientific Inc.

11.6.1 Company Overview

11.6.2 Application Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 CLC Bio

11.7.1 Overview

11.7.2 Application Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Agilent Technologies Inc.

11.8.1 Company Overview

11.8.2 Applications/Business Segment Overview

11.8.3 Financial Overview

11.8.4 Key Development

11.8.5 SWOT Analysis

11.9 Macrogen Inc.

11.9.1 Company Overview

11.9.2 Application Overview

11.9.3 Financial overview

11.9.4 Key Developments

11.10 Helicos BioSciences

11.10.1 Company Overview

11.10.2 Application Overview

11.10.3 Financial overview

11.10.4 Key Developments

11.11 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Pharmaceutical industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Metagenomic sequencing Industry Synopsis, 2023-2032

Table 2 Metagenomic sequencing Market Estimates and Forecast, 2023-2032, (USD Million)

Table 3 Metagenomic sequencing Market by Region, 2023-2032, (USD Million)

Table 4 Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)

Table 5 Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)

Table 6 Metagenomic sequencing Market by End Users, 2023-2032, (USD Million)

Table 7 North America Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)

Table 8 North America Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)

Table 9 North America Metagenomic sequencing Market by End User, 2023-2032, (USD Million)

Table 10 US Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)

Table 11 US Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)

Table 12 US Metagenomic sequencing Market by End User, 2023-2032, (USD Million)

Table 13 Canada Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)

Table 14 Canada Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)

Table 15 Canada Metagenomic sequencing Market by End User, 2023-2032, (USD Million)

Table 16 South America Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)

Table 17 South America Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)

Table 18 South America Metagenomic sequencing Market by End User, 2023-2032, (USD Million)

Table 19 Europe Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)

Table 20 Europe Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)

Table 21 Europe Metagenomic sequencing Market by End User, 2023-2032, (USD Million)

Table 22 Western Europe Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)

Table 23 Western Europe Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)

Table 24 Western Europe Metagenomic sequencing Market by End User, 2023-2032, (USD Million)

Table 25 Eastern Europe Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)

Table 26 Eastern Europe Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)

Table 27 Eastern Europe Metagenomic sequencing Market by End User, 2023-2032, (USD Million)

Table 28 Asia Pacific Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)

Table 29 Asia Pacific Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)

Table 30 Asia Pacific Metagenomic sequencing Market by End User, 2023-2032, (USD Million)

Table 31 The Middle East & Africa Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)

Table 32 The Middle East & Africa Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)

Table 33 The Middle East & Africa Metagenomic sequencing Market by End User, 2023-2032, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Metagenomic sequencing Market

Figure 3 Segmentation Market Dynamics for Metagenomic sequencing Market

Figure 4 Global Metagenomic sequencing Market Share, by Technology 2020

Figure 5 Global Metagenomic sequencing Market Share, by Application2020

Figure 6 Global Metagenomic sequencing Market Share, by End Users, 2020

Figure 7 Global Metagenomic sequencing Market Share, by Region, 2020

Figure 8 North America Metagenomic sequencing Market Share, by Country, 2020

Figure 9 Europe Metagenomic sequencing Market Share, by Country, 2020

Figure 10 Asia Pacific Metagenomic sequencing Market Share, by Country, 2020

Figure 11 The Middle East & Africa Metagenomic sequencing Market Share, by Country, 2020

Figure 12 Global Metagenomic sequencing Market: Company Share Analysis, 2020 (%)

Figure 13 GATC Biotech AG: Key Financials

Figure 14 GATC Biotech AG: Segmental Revenue

Figure 15 GATC Biotech AG: Geographical Revenue

Figure 16 Enterome Bioscience: Key Financials

Figure 17 Enterome Bioscience: Segmental Revenue

Figure 18 Enterome Bioscience: Geographical Revenue

Figure 19 Illumina Inc.: Key Financials

Figure 20 Illumina Inc.: Segmental Revenue

Figure 22 Illumina Inc.: Geographical Revenue

Figure 23 Quest Diagnostics: Key Financials

Figure 24 Quest Diagnostics: Segmental Revenue

Figure 25 Quest Diagnostics: Geographical Revenue

Figure 27 F Hoffman-La Roche Ltd.: Key Financials

Figure 28 F Hoffman-La Roche Ltd.: Segmental Revenue

Figure 29 F Hoffman-La Roche Ltd.: Geographical Revenue

Figure 30 Thermo Fisher Scientific Inc.: Key Financials

Figure 32 Thermo Fisher Scientific Inc.: Segmental Revenue

Figure 33 Thermo Fisher Scientific Inc.: Geographical Revenue

Figure 33 Tornier N.V.: Key Financials

Figure 34 Tornier N.V.: Segmental Revenue

Figure 35 Tornier N.V.: Geographical Revenue

Figure 36 Össur: Key Financials

Figure 37 Össur: Segmental Revenue

Figure 38 Össur: Geographical Revenue

Figure 39 Acumed, LLC: Key Financials

Figure 40 Acumed, LLC: Segmental Revenue

Figure 41 Acumed, LLC: Geographical Revenue

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.